Prospects for gene replacement therapies in amyotrophic lateral sclerosis. (2023)
Attributed to:
Gene Therapy Innovation and Manufacturing Centre (GTIMC)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41582-022-00751-5
PubMed Identifier: 36481799
Publication URI: http://europepmc.org/abstract/MED/36481799
Type: Journal Article/Review
Volume: 19
Parent Publication: Nature reviews. Neurology
Issue: 1
ISSN: 1759-4758